Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Cash & Equivalents (2023 - 2025)

Solventum (SOLV) has disclosed Cash & Equivalents for 3 consecutive years, with $1.6 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 112.69% year-over-year to $1.6 billion, compared with a TTM value of $1.6 billion through Sep 2025, up 112.69%, and an annual FY2024 reading of $762.0 million, up 292.78% over the prior year.
  • Cash & Equivalents was $1.6 billion for Q3 2025 at Solventum, up from $492.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.6 billion in Q3 2025 and bottomed at $194.0 million in Q4 2023.
  • Average Cash & Equivalents over 3 years is $786.1 million, with a median of $767.0 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents soared 292.78% in 2024, then crashed 46.39% in 2025.
  • Year by year, Cash & Equivalents stood at $194.0 million in 2023, then skyrocketed by 292.78% to $762.0 million in 2024, then skyrocketed by 115.49% to $1.6 billion in 2025.
  • Business Quant data shows Cash & Equivalents for SOLV at $1.6 billion in Q3 2025, $492.0 million in Q2 2025, and $534.0 million in Q1 2025.